[Recommendations for the screening for infectious diseases, mental health, and female genital mutilation in immigrant patients seen in Primary Care]

Ethel Sequeira-Aymar, Ximena diLollo, Yolanda Osorio-Lopez, Alessandra Queiroga Gonçalves, Carme Subirà, Ana Requena-Méndez, Ethel Sequeira-Aymar, Ximena diLollo, Yolanda Osorio-Lopez, Alessandra Queiroga Gonçalves, Carme Subirà, Ana Requena-Méndez

Abstract

Immigrant health status may be improved if certain health conditions are identified early through the implementation of a screening program. This document presents the recommendations resulting from the Screening in immigrant population project (CRIBMI) aimed at implementing a screening program for infectious diseases (HIV, HBV, HCV, tuberculosis, strongyloidiasis, schistosomiasis and Chagas disease), as well as female genital mutilation and mental health (MH) in migrant population at Primary Care level. Screening recommendations were based on: coming from an endemic country for strongyloidiasis, schistosomiasis, and Chagas diseases; on a threshold level of prevalence for HIV (> 1%), HBV (> 2%), and HCV (> 2%), and on incidence (> 50 cases/100,000-inhabitants) for active tuberculosis in immigrants with < 5 years in Europe. Exploring the risk of FGM is recommended in women from countries where this practice is prevalent. Evaluation of MH status is recommended for people from areas of conflict and violence.

Keywords: Atención Primaria; Cribaje; Female genital mutilation; Infecciones; Infections; Mental health; Migración; Migrations; Mutilación genital femenina; Primary Care; Salud mental; Screening.

Copyright © 2019. Publicado por Elsevier España, S.L.U.

Figures

Figura 1
Figura 1
Mapa recomendación CRIBMI de cribado de VIH.

References

    1. World Health Organization: The way forward. Report of a Global consultation. Madrid, 2010. Disponible en:
    1. España en cifras 2018. En: Estadística INd, editor. Madrid: Instituto Nacional de Estadística; 2018.
    1. Bradby H, Humphris R, Newall D, Phillimore J. Public health aspects of migrant health: a review of the evidence on health status for refugees and asylum seekers in the European Region. Copenhagen: WHO Regional Office for Europe; 2015 (Health Evidence Network synthesis report 44).
    1. European Centre for Disease Prevention, Control Assessing the burden of key infectious diseases affecting migrant populations in the EU/EEA. Stockholm: ECDC; 2014
    1. Pottie K., Greenaway C., Feightner J., Welch V., Swinkels H., Rashid M. Evidence-based clinical guidelines for immigrants and refugees. CMAJ. 2011;183:E824–E925.
    1. Generalitat de Catalunya . Barcelona; 2011. Protocol per a ĺabordatge de la violència masclista en ĺàmbit de la salut a Catalunya. Dossier 3. Document operatiu de mutilació genital femenina.
    1. Kirmayer L.J., Narasiah L., Munoz M., Rashid M., Ryder A.G., Guzder J. Common mental health problems in immigrants and refugees: general approach in primary care. CMAJ. 2011;183:E959–E967.
    1. ECDC. ECDC issues migrant screening and vaccination guidance. In: ECDC, editor. Stockholm: ECDC; 2018.
    1. Public Health England. Guidance on NHS entitlements: Migrant health guide (web page) [consultado 15 Feb 2019]. Disponible en:
    1. Health Protection Surveillance Centre. Infectious Disease Assessment for Migrants. Dublin 2015. Disponible en:
    1. Pottie K., Greenaway C., Feightner J., Welch V., Swinkels H., Rashid M. Evidence-based clinical guidelines for immigrants and refugees. CMAJ. 2011;183:E824–E925.
    1. Chaves N.J., Paxton G.A., Biggs B.A., Thambiran A., Gardiner J., Williams J. The Australasian Society for Infectious Diseases and Refugee Health Network of Australia recommendations for health assessment for people from refugee-like backgrounds: An abridged outline. Med J Aust. 2017;206:310–315.
    1. Centre for Disease Control and Prevention. Immigrant and Refugee Health. U.S. Department of Health & Human Services. Web page [consultado 15 Feb 2019]. Disponible en:
    1. Salama P., Dondero T.J. HIV surveillance in complex emergencies. AIDS (London, England). 2001;15(Suppl 3):S4–S12.
    1. European Centre for Disease Prevention and Control. HIV and AIDS. En: ECDC. Annual epidemiological report for 2015. Stockholm: ECDC; 2017.
    1. European Centre for Disease Prevention and Control. Implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2010 progress report. Stockholm: ECDC; 2010.
    1. Lohse N. The road to success. Long-term prognosis for persons living with HIV in Denmark —time trends and risk factors. Dan Med J. 2016;63
    1. Kramer M.A., van Veen M.G., Op de Coul E.L.M., Geskus R.B., Coutinho R.A., van de Laar M.J.W. Migrants travelling to their country of origin: A bridge population for HIV transmission? Sex Transm Infect. 2008;84:554–555.
    1. World Health Organization. Global tuberculosis report 2018. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO.
    1. Sotgiu G., Migliori G.B. Prevention of tuberculosis transmission through medical surveillance systems. Lancet Public Health. 2017;2:e439–e4402.
    1. Rantala M. Survelliance and epiddemiology of hepatitis B and C in Europe —a review. Euro Surveill. 2008;13
    1. Ferrante J.M., Winston D.G., Chen P.-H., de la Torre A.N. Family physicians’ knowledge and screening of chronic hepatitis and liver cancer. Fam Med. 2008;40:345–351.
    1. Bottero J., Boyd A., Gozlan J., Carrat F., Nau J., Pauti M.-D. Simultaneous human immunodeficiency virus-hepatitis B-hepatitis C point-of-care tests improve outcomes in linkage-to-care: Results of a randomized control trial in persons without healthcare coverage. Open Forum Infect Dis. 2015;2 ofv162.
    1. European Centre for Disease Prevention and Control Epidemiological assessment of hepatitis B and C among migrants in the EU/EEA. Stockholm: ECDC. 2016
    1. European Centre for Disease Prevention and Control/WHO Regional Office for Europe Tuberculosis surveillance and monitoring in Europe 2014. Stockholm: European Centre for Disease Prevention and Control. 2014
    1. Aldridge R.W., Zenner D., White P.J., Williamson E.J., Muzyamba M.C., Dhavan P. Tuberculosis in migrants moving from high-incidence to low-incidence countries: A population-based cohort study of 519 955 migrants screened before entry to England, Wales, and Northern Ireland. Lancet (London, England). 2016;388:2510–2518.
    1. Falzon D., Ait-Belghiti F. What is tuberculosis surveillance in the European Union telling us? Clin Infect Dis. 2007;44:1261–1267.
    1. Greenaway C., Pareek M., Abou Chakra C.N., Walji M., Makarenko I., Alabdulkarim B. The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: A systematic review. Euro Surveill. 2018;23
    1. World Health Organization. TB burden estimates, notifications and treatment outcomes for individual countries and territories, WHO regions and the world. (Global tuberculosis report 2018), Annex 4. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO.
    1. Campbell J.R., Chen W., Johnston J., Cook V., Elwood K., Krot J. Latent tuberculosis infection screening in immigrants to low-incidence countries: A meta-analysis. Mol Diagn Ther. 2015;19:107–117.
    1. Greenaway C., Pareek M., Abou Chakra C.N., Walji M., Makarenko I., Alabdulkarim B. The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: A systematic review. Euro Surveill. 2018;23
    1. Bisoffi Z., Buonfrate D., Sequi M., Mejia R., Cimino R.O., Krolewiecki A.J. Diagnostic accuracy of five serologic tests for Strongyloides stercoralis infection. PLoS Negl Trop Dis. 2014;8:e2640–e2650.
    1. King C.H. Parasites and poverty: The case of schistosomiasis. Acta Trop. 2010;113:95–104.
    1. Belhassen-Garcia M., Alonso-Sardon M., Martinez-Perez A., Soler C., Carranza-Rodriguez C., Perez-Arellano J.L. Surveillance of strongyloidiasis in Spanish in-patients (1998-2014) PLoS One. 2017;12:e0189449.
    1. Requena-Mendez A., Buonfrate D., Gomez-Junyent J., Zammarchi L., Bisoffi Z., Munoz J. Evidence-based guidelines for screening and management of strongyloidiasis in non-endemic countries. Am J Trop Med Hyg. 2017;97:645–652.
    1. Buonfrate D., Requena-Mendez A., Angheben A., Munoz J., Gobbi F., van den Ende J. Severe strongyloidiasis: A systematic review of case reports. BMC Infect Dis. 2013;13:78–80.
    1. Colley D.G., Bustinduy A.L., Secor W.E., King C.H. Human schistosomiasis. The Lancet. 2014;383:2253–2264.
    1. Requena-Méndez A., Chiodini P., Bisoffi Z., Buonfrate D., Gotuzzo E., Muñoz J. The laboratory diagnosis and follow up of strongyloidiasis: A systematic review. PLoS Negl Trop Dis. 2013;7:e2002–e2010.
    1. Requena-Mendez A., Chiodini P., Bisoffi Z., Buonfrate D., Gotuzzo E., Munoz J. The laboratory diagnosis and follow up of strongyloidiasis: A systematic review. PLoS Negl Trop Dis. 2013;7:e2002–e2010.
    1. Kinkel H.F., Dittrich S., Baumer B., Weitzel T. Evaluation of eight serological tests for diagnosis of imported schistosomiasis. Clin Vaccine Immunol. 2012;19:948–953.
    1. Ochodo EA, Gopalakrishna G, Spek B, Reitsma JB, van Lieshout L, Polman K, et al. Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas. En: Ochodo EA, editor. Chichester, UK: John Wiley & Sons, Ltd; 2015.
    1. Espirito-Santo M.C., Sanchez M.C., Sanchez A.R., Alvarado-Mora M.V., Castilho V.L., Goncalves E.M. Evaluation of the sensitivity of IgG and IgM ELISA in detecting Schistosoma mansoni infections in a low endemicity setting. Eur J Clin Microbiol Infect Dis. 2014;33:2275–2284.
    1. Pérez del Villar L., Burguillo F.J., López-Abán J., Muro A. Systematic review meta-analysis of artemisinin based therapies for the treatment prevention of schistosomiasis. PLOS ONE. 2012;7:e45867–e45870.
    1. Henriquez-Camacho C, Gotuzzo E, Echevarria J, White Jr AC, Terashima A, Samalvides F, et al. Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. En: Henriquez-Camacho C, editor. Chichester, UK: John Wiley & Sons, Ltd; 2016.
    1. Buonfrate D., Mena M.A., Angheben A., Requena-Mendez A., Munoz J., Gobbi F. Prevalence of strongyloidiasis in Latin America: A systematic review of the literature. Epidemiol Infect. 2015;143:452–460.
    1. Requena-Mendez A., Albajar-Vinas P., Angheben A., Chiodini P., Gascon J., Munoz J. Health policies to control Chagas disease transmission in European countries. PLoS Negl Trop Dis. 2014;8:e3245–e3250.
    1. Requena-Mendez A., Lopez M.C., Angheben A., Izquierdo L., Ribeiro I., Pinazo M.J. Evaluating Chagas disease progression and cure through blood-derived biomarkers: A systematic review. Expert Rev Anti Infect Ther. 2013;11:957–976.
    1. Morillo C.A., Marin-Neto J.A., Avezum A., Sosa-Estani S., Rassi A., Rosas F. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. N Eng J Med. 2015;373:1295–1306.
    1. Requena-Mendez A., Bussion S., Aldasoro E., Jackson Y., Angheben A., Moore D. Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: A Markov model analysis. Lancet Glob Health. 2017;5:e439–e447.
    1. Heinz A., Kluge U. Mental health in different groups of migrants and ethnic minority within Europe and beyond: regional and cross-national challenges and approaches in research, practice and training. Eur Psychiatry. 2012;27(Suppl 2):S1–S3.
    1. Tran T.V., Manalo V., Nguyen V.T.D. Nonlineal relationship between length of residence and depression in a community-based sample of Vietnamese Americans. Int J Soc Psychiatry. 2007;53:85–94.
    1. Lustig S.L., Kia-Keating M., Knight W.G., Geltman P., Ellis H., Kinzie J.D. Review of child and adolescent refugee mental health. J Am Acad Child Adolesc Psychiatry. 2004;43:24–36.
    1. Norredam M., Garcia-Lopez A., Keiding N., Krasnik A. Risk of mental disorders in refugees and native Danes: A register-based retrospective cohort study. Soc Psychiatry Psychiatr Epidemiol. 2009;44:1023–1029.
    1. Fazel M., Wheeler J., Danesh J. Prevalence of serious mental disorder in 7000 refugees resettled in western countries: A systematic review. Lancet (London, England). 2005;365:1309–1314.
    1. Steel Z., Chey T., Silove D., Marnane C., Bryant R.A., van Ommeren M. Association of torture and other potentially traumatic events with mental health outcomes among populations exposed to mass conflict and displacement: A systematic review and meta-analysis. JAMA. 2009;302:537–549.
    1. Escola de Cultura de Pau. Alerta 2018 . Icaria Editorial; Barcelona: 2018. Informe sobre conflictos, derechos humanos y construcción de paz.
    1. Van’t Hoog A.H., Langendam M., Mitchell E., Cobelens F.G., Sinclair D., Leeflang M.M. Symptom- and chest-radiography screening for active pulmonary tuberculosis in HIV-negative adults and adults with unknown HIV status. Cochrane Database Syst Rev. 2014 Issue 1. Art. No.: CD010890.
    1. Menacho I., Sequeira E., Muns M., Barba O., Leal L., Clusa T. Comparison of 2 HIV testing strategies in primary care centres: indicator-condition-guided testing vs. testing of those with non-indicator conditions. HIV Med. 2013;14(Suppl 3):33–37.
    1. Seedat F., Hargreaves S., Nellums L.B., Ouyang J., Brown M., Friedland J.S. How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review. Lancet Infect Dis. 2018;18:e259–e271.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren